Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 885
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A 5-year clinical follow-up study from the Italian National Registry for FSHD 2021 Angelini C.Pegoraro E. + JOURNAL OF NEUROLOGY - -
Governance of Access in Biobanking: The Case of Telethon Network of Genetic Biobanks 2021 Elena PegoraroCorrado Angelini + BIOPRESERVATION AND BIOBANKING - -
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis 2021 Angelini C. + EXPERT REVIEW OF NEUROTHERAPEUTICS - -
ETF dehydrogenase advances in molecular genetics and impact on treatment 2021 Angelini C. + CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY - -
Circulating miR-206 as a biomarker for patients affected by severe limb girdle muscle dystrophies 2021 Angelini C. + GENES - -
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 2020 Angelini C.Pegoraro E. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Can miR-34a be suitable for monitoring sensorineural hearing loss in patients with mitochondrial disease? A case series 2020 Corrado Angelini + INTERNATIONAL JOURNAL OF NEUROSCIENCE - -
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy 2020 Angelini C. + NEUROLOGICAL SCIENCES - -
MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy 2020 Corrado Angelini + DIAGNOSTICS - -
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 2020 Angelini C.Pegoraro E. + JAMA NETWORK OPEN - -
Can miR-34a be suitable for monitoring sensorineural hearing loss in patients with mitochondrial disease? A case series 2020 Corrado Angelini + INTERNATIONAL JOURNAL OF NEUROSCIENCE - -
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy 2020 Baba A.Angelini C. + NEUROLOGICAL SCIENCES - -
Assessing diagnosis and managing respiratory and cardiac complications of sarcoglycanopathy 2020 Angelini C. + EXPERT OPINION ON ORPHAN DRUGS - -
MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy 2020 Corrado Angelini + DIAGNOSTICS - -
EFNS gudelines 2020 Angelini C + MUSCLE & NERVE - -
Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis 2020 Pegoraro E.Angelini C. + SCIENTIFIC REPORTS - -
Transportin 3 (TNPO3) and related proteins in limb girdle muscular dystrophy D2 muscle biopsies: A morphological study and pathogenetic hypothesis 2020 Vianello S.Pegoraro E.Angelini C. + NEUROMUSCULAR DISORDERS - -
Advances in imaging of brain abnormalities in neuromuscular disease 2019 Angelini C. + THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS - -
Advances in imaging of brain abnormalities in neuromuscular disease 2019 Angelini C. + THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS - -
A new family with transportinopathy: increased clinical heterogeneity 2019 Angelini C. + THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS - -
Mostrati risultati da 1 a 20 di 885
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile